Prognostic factors in men with metastatic castration-resistant prostate cancer treated with cabazitaxel

por Belderbos, Bodine P.S., de Wit, Ronald, Hoop, Esther Oomen-de, Nieuweboer, Annemieke, Hamberg, Paul, van Alphen, Robbert J., Bergman, André, van der Meer, Nelly, Bins, Sander, Mathijssen, Ron H.J., van Soest, Robert J.
Publicado 2017

Association between Paclitaxel Clearance and Tumor Response in Patients with Esophageal Cancer

por Toxopeus, Eelke L.A., de Man, Femke M., Krak, Nanda, Biermann, Katharina, Nieuweboer, Annemieke J.M., Friberg, Lena E., Oomen-de Hoop, Esther, van Lanschot, Jan J.B., Shapiro, Joel, Wijnhoven, Bas P.L., Mathijssen, Ron H.J.
Publicado 2019

AR splice variants in circulating tumor cells of patients with castration‐resistant prostate cancer: relation with outcome to cabazitaxel

por Sieuwerts, Anieta M., Onstenk, Wendy, Kraan, Jaco, Beaufort, Corine M., Van, Mai, De Laere, Bram, Dirix, Luc Y., Hamberg, Paul, Beeker, Aart, Meulenbeld, Hielke J., Creemers, Geert‐Jan, van Weerden, Wytske M., Jenster, Guido W., Nieuweboer, Annemieke J. M., Mathijssen, Ron H. J., de Wit, Ronald, Martens, John W. M., Sleijfer, Stefan
Publicado 2019

Genome-wide association study of paclitaxel and carboplatin disposition in women with epithelial ovarian cancer

por Gao, Bo, Lu, Yi, Nieuweboer, Annemieke J. M., Xu, Hongmei, Beesley, Jonathan, Boere, Ingrid, de Graan, Anne-Joy M., de Bruijn, Peter, Gurney, Howard, J. Kennedy, Catherine, Chiew, Yoke-Eng, Johnatty, Sharon E., Beale, Philip, Harrison, Michelle, Luccarini, Craig, Conroy, Don, Mathijssen, Ron H. J., R. Harnett, Paul, Balleine, Rosemary L., Chenevix-Trench, Georgia, Macgregor, Stuart, de Fazio, Anna
Publicado 2018